TEMOVATE E SUMMARY
Temovate® E (clobetasol propionate) Cream, 0.05% contains the active compound clobetasol propionate, a synthetic
corticosteroid, for topical use. Clobetasol, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight
degree of mineralocorticoid activity.
Temovate® E is a super-high potency corticosteroid indicated for:
Temovate® E is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive
dermatoses in patients 12 years of age and older. Treatment should be limited to 2 consecutive weeks, and the total dosage
should not exceed 50 grams per week.
Moderate to Severe Plaque-Type Psoriasis
Temovate®E is indicated for the topical treatment of moderate to severe plaque-type psoriasis. Treatment beyond 4
consecutive weeks is not recommended. Use in pediatric patients under 16 years of age is not recommended.
Limitations of Use
should not be used in the treatment of rosacea or perioral dermatitis, and should not be used on the face, groin, or axillae.
The total dosage should not exceed 50 grams per week.
Avoid use if skin atrophy is present at the treatment site.